Cefdinir and Toprol-xl drug interactions - a phase IV clinical study of FDA data


Drug interactions are reported among 24 people who take Cefdinir and Toprol-xl. Common interactions include red cell distribution width increased among females, and cardiac murmur among males.

The phase IV clinical study analyzes what interactions people who take Cefdinir and Toprol-xl have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

24 people who take Cefdinir and Toprol-xl together, and have interactions are studied.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is used in sinusitis. Currently, eHealthMe is studying from 8,628 Cefdinir users.

What is Toprol-xl?

Toprol-xl has active ingredients of metoprolol succinate. It is used in high blood pressure. Currently, eHealthMe is studying from 40,607 Toprol-xl users.

Number of Cefdinir and Toprol-xl reports submitted per year:

Cefdinir and Toprol-xl drug interactions.

Common Cefdinir and Toprol-Xl drug interactions by gender *:


  1. Red cell distribution width increased
  2. Weight increased
  3. Actinic keratosis
  4. Acute myocardial infarction
  5. Asthenia
  6. Atelectasis
  7. Brachial plexopathy
  8. Bursitis
  9. Cerebral atrophy
  10. Chest discomfort


  1. Cardiac murmur
  2. Heart rate irregular
  3. Palpitations
  4. Pneumonia
  5. Blood glucose increased
  6. Dyspnoea exertional
  7. Multiple injuries
  8. Nodal rhythm
  9. Ageusia
  10. Asthma

Common Cefdinir and Toprol-Xl drug interactions by age *:








  1. Vertigo
  2. Anxiety
  3. Emotional distress
  4. General physical health deterioration
  5. Headache
  6. Injury
  7. Mental disorder
  8. Migraine
  9. Nausea
  10. Neck pain




  1. Thyroid cancer metastatic


  1. Dizziness
  2. Dyslipidaemia
  3. Headache
  4. Injury
  5. Insomnia
  6. Joint swelling
  7. Palpitations
  8. Pneumonia
  9. Abdominal pain
  10. Abdominal pain upper


  1. Cardiac failure congestive
  2. Abdominal pain
  3. Dehydration
  4. Gastric ulcer
  5. Renal failure acute
  6. Respiratory failure
  7. Sinus tachycardia
  8. Urosepsis
  9. Ventricular fibrillation
  10. Weight decreased

Common conditions people have *:

  1. Arrhythmias (irregular heartbeat): 9 people, 37.50%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 16.67%
  3. Premenstrual Syndrome: 2 people, 8.33%
  4. Migraine (headache): 2 people, 8.33%
  5. Heart Rate Irregular: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Toprol-xl?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Cefdinir drug interactions:

Browse interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Toprol-xl drug interactions:

Browse interactions between Toprol-xl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and metoprolol succinate (the active ingredients of Cefdinir and Toprol-xl, respectively), and Cefdinir and Toprol-xl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cefdinir and Toprol-xl.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: